Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

Editorial

  • Editorial
    Molecular Imaging in Oncology: The Diagnostic Imaging “Revolution”
    Steven M. Larson
    Clin Cancer Res June 1 2000 6 (6) 2125-2125;

  • Editorial
    Are We Ready to Use Surrogate End Points and Surrogate Tissues to Evaluate Response to Chemopreventive and Therapeutic Intervention?
    Reuben Lotan
    Clin Cancer Res June 1 2000 6 (6) 2126-2128;

Review

  • Review
    Detection of Mutated KRAS2 Sequences as Tumor Markers in Plasma/Serum of Patients with Gastrointestinal Cancer
    George D. Sorenson
    Clin Cancer Res June 1 2000 6 (6) 2129-2137;

  • Review
    Gain-of-Function Mutations in the Tumor Suppressor Gene p53
    Monique G. C. T. van Oijen and Pieter J. Slootweg
    Clin Cancer Res June 1 2000 6 (6) 2138-2145;

Advances in Brief

  • Advances in Brief
    Rapid in Vivo Monitoring of Chemotherapeutic Response Using Weighted Sodium Magnetic Resonance Imaging
    Richard P. Kline, Ed X. Wu, Daniel P. Petrylak, Matthias Szabolcs, Philip O. Alderson, Myron L. Weisfeldt, Paul Cannon and Jose Katz
    Clin Cancer Res June 1 2000 6 (6) 2146-2156;

  • Advances in Brief
    Intratumoral Administration of Recombinant Circularly Permuted Interleukin-4-Pseudomonas Exotoxin in Patients with High-Grade Glioma
    Robert W. Rand, Robert J. Kreitman, Nicholas Patronas, Frederick Varricchio, Ira Pastan and Raj K. Puri
    Clin Cancer Res June 1 2000 6 (6) 2157-2165;

  • Advances in Brief
    Modulation of Radiation Response after Epidermal Growth Factor Receptor Blockade in Squamous Cell Carcinomas: Inhibition of Damage Repair, Cell Cycle Kinetics, and Tumor Angiogenesis
    Shyh-Min Huang and Paul M. Harari
    Clin Cancer Res June 1 2000 6 (6) 2166-2174;

  • Advances in Brief
    Priming Tissue-specific Cellular Immunity in a Phase I Trial of Autologous Dendritic Cells for Prostate Cancer
    Patrick A. Burch, Jami K. Breen, Jan C. Buckner, Dennis A. Gastineau, Judith A. Kaur, Reiner L. Laus, Douglas J. Padley, Madhusudan V. Peshwa, Henry C. Pitot, Ronald L. Richardson, Bouwien J. Smits, Pitsata Sopapan, George Strang, Frank H. Valone and Stanimir Vuk-Pavlović
    Clin Cancer Res June 1 2000 6 (6) 2175-2182;

  • Advances in Brief
    Quantitative Analysis of Circulating Tumor Cells in Peripheral Blood of Osteosarcoma Patients Using Osteoblast-specific Messenger RNA Markers: A Pilot Study
    Ivy H. N. Wong, Andrew T. Chan and Philip J. Johnson
    Clin Cancer Res June 1 2000 6 (6) 2183-2188;

Clinical Trials

  • Clinical Trials
    High Microvascular Blood Volume Is Associated with High Glucose Uptake and Tumor Angiogenesis in Human Gliomas
    Hannu J. Aronen, Francisco S. Pardo, David N. Kennedy, John W. Belliveau, Scott D. Packard, Dora W. Hsu, Frederick H. Hochberg, Alan J. Fischman and Bruce R. Rosen
    Clin Cancer Res June 1 2000 6 (6) 2189-2200;

  • Clinical Trials
    A Phase II Pilot Trial of Concurrent Biochemotherapy with Cisplatin, Vinblastine, Dacarbazine, Interleukin 2, and Interferon α-2B in Patients with Metastatic Melanoma
    David F. McDermott, James W. Mier, Donald P. Lawrence, Marcel R. M. van den Brink, Marquerite A. Clancy, Krista M. Rubin and Michael B. Atkins
    Clin Cancer Res June 1 2000 6 (6) 2201-2208;

  • Clinical Trials
    T Cell Adoptive Immunotherapy of Newly Diagnosed Gliomas
    Gregory E. Plautz, David W. Miller, Gene H. Barnett, Glen H. J. Stevens, Scott Maffett, Julian Kim, Peter A. Cohen and Suyu Shu
    Clin Cancer Res June 1 2000 6 (6) 2209-2218;

  • Clinical Trials
    Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinomas
    Margaret von Mehren, Philip Arlen, Kwong Y. Tsang, André Rogatko, Neal Meropol, Harry S. Cooper, Monica Davey, Susan McLaughlin, Jeffrey Schlom and Louis M. Weiner
    Clin Cancer Res June 1 2000 6 (6) 2219-2228;

  • Clinical Trials
    The Effects of Neoadjuvant Anastrozole (Arimidex) on Tumor Volume in Postmenopausal Women with Breast Cancer: A Randomized, Double-Blind, Single-Center Study
    J. Michael Dixon, Lorna Renshaw, Chris Bellamy, Mary Stuart, Guido Hoctin-Boes and William R. Miller
    Clin Cancer Res June 1 2000 6 (6) 2229-2235;

  • Clinical Trials
    Phase I Dose-finding and Pharmacokinetic Trial of Irinotecan Hydrochloride (CPT-11) Using a Once-Every-Three-Week Dosing Schedule for Patients with Advanced Solid Tumor Malignancy
    Henry C. Pitot, Richard M. Goldberg, Joel M. Reid, Jeff A. Sloan, Pam Atherton Skaff, Charles Erlichman, Joseph Rubin, Patrick A. Burch, Alex A. Adjei, Steven A. Alberts, Larry J. Schaaf, Gary Elfring and Langdon L. Miller
    Clin Cancer Res June 1 2000 6 (6) 2236-2244;

  • Clinical Trials
    Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole
    Qing Zeng, David C. Smith, Todd J. Suscovich, William E. Gooding, Donald L. Trump and Jennifer Rubin Grandis
    Clin Cancer Res June 1 2000 6 (6) 2245-2251;

  • Clinical Trials
    Imaging of Soft-Tissue Tumors Using l-3-[Iodine-123]Iodo-α-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity
    Pieter L. Jager, Boudewijn E. C. Plaat, Elisabeth G. E. de Vries, Willemina M. Molenaar, Willem Vaalburg, D. Albertus Piers and Harald J. Hoekstra
    Clin Cancer Res June 1 2000 6 (6) 2252-2259;

  • Clinical Trials
    Antiproliferative Effects of Idoxifene in a Placebo-controlled Trial in Primary Human Breast Cancer
    Mitch Dowsett, J. Michael Dixon, Kieran Horgan, Janine Salter, Margaret Hills and Eileen Harvey
    Clin Cancer Res June 1 2000 6 (6) 2260-2267;

  • Clinical Trials
    Clinical and Biological Effects of Intraperitoneal Injections of Recombinant Interferon-γ and Recombinant Interleukin 2 with or without Tumor-infiltrating Lymphocytes in Patients with Ovarian or Peritoneal Carcinoma
    Ralph S. Freedman, Andrzej P. Kudelka, John J. Kavanagh, Claire Verschraegen, Creighton L. Edwards, Micheal Nash, Lawrence Levy, Edward N. Atkinson, Hua-Zhong Zhang, Bohuslav Melichar, Rebecca Patenia, Stacie Templin, Wanza Scott and Chris D. Platsoucas
    Clin Cancer Res June 1 2000 6 (6) 2268-2278;

  • Clinical Trials
    Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients
    Giuseppe Toffoli, Roberto Sorio, Paola Aita, Diana Crivellari, Giuseppe Corona, Alessandra Bearz, Isabel Robieux, Anna Maria Colussi, Franco Stocco and Mauro Boiocchi
    Clin Cancer Res June 1 2000 6 (6) 2279-2287;

  • Clinical Trials
    Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule
    Noriyuki Masuda, Kaoru Matsui, Nobuyuki Yamamoto, Toshiji Nogami, Kazuhiko Nakagawa, Shunichi Negoro, Kouji Takeda, Nobuhide Takifuji, Masaji Yamada, Shinzoh Kudoh, Teruyoshi Okuda, Shinjiroh Nemoto, Kanako Ogawa, Hiroshi Myobudani, Shinichi Nihira and Masahiro Fukuoka
    Clin Cancer Res June 1 2000 6 (6) 2288-2294;

Molecular Oncology, Markers, Clinical Correlates

  • Molecular Oncology, Markers, Clinical Correlates
    Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers
    Hiroki Kuniyasu, Patricia Troncoso, Dennis Johnston, Corazon D. Bucana, Eiichi Tahara, Isaiah J. Fidler and Curtis A. Pettaway
    Clin Cancer Res June 1 2000 6 (6) 2295-2308;

  • Molecular Oncology, Markers, Clinical Correlates
    Extracellular Catalytic Subunit Activity of the cAMP-dependent Protein Kinase in Prostate Cancer
    Mary Ellen Cvijic, Tsunekazu Kita, Weichung Shih, Robert S. DiPaola and Khew-Voon Chin
    Clin Cancer Res June 1 2000 6 (6) 2309-2317;

  • Molecular Oncology, Markers, Clinical Correlates
    Comparison of Potential Markers of Farnesyltransferase Inhibition
    Alex A. Adjei, Jenny N. Davis, Charles Erlichman, Phyllis A. Svingen and Scott H. Kaufmann
    Clin Cancer Res June 1 2000 6 (6) 2318-2325;

  • Molecular Oncology, Markers, Clinical Correlates
    Genetic Detection for Micrometastasis in Lymph Node of Biliary Tract Carcinoma
    Jiro Okami, Keizo Dohno, Masato Sakon, Kyoko Iwao, Terumasa Yamada, Hirofumi Yamamoto, Yoshiyuki Fujiwara, Hiroaki Nagano, Koji Umeshita, Nariaki Matsuura, Shoji Nakamori and Morito Monden
    Clin Cancer Res June 1 2000 6 (6) 2326-2332;

  • Molecular Oncology, Markers, Clinical Correlates
    Enhanced Urinary Gelatinase Activities (Matrix Metalloproteinases 2 and 9) Are Associated with Early-Stage Bladder Carcinoma: A Comparison with Clinically Used Tumor Markers
    Cornelis F. M. Sier, Giovanni Casetta, Jan H. Verheijen, Alessandro Tizzani, Vittorio Agape, Janko Kos, Francesco Blasi and Roeland Hanemaaijer
    Clin Cancer Res June 1 2000 6 (6) 2333-2340;

  • Molecular Oncology, Markers, Clinical Correlates
    Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Endometrial Carcinomas
    Tomoya Segawa, Toshiyuki Sasagawa, Kiyofumi Saijoh and Masaki Inoue
    Clin Cancer Res June 1 2000 6 (6) 2341-2348;

  • Molecular Oncology, Markers, Clinical Correlates
    Matrix Metalloproteinase 9 and the Epidermal Growth Factor Signal Pathway in Operable Non-Small Cell Lung Cancer
    Giles Cox, J. Louise Jones and Kenneth J. O’Byrne
    Clin Cancer Res June 1 2000 6 (6) 2349-2355;

  • Molecular Oncology, Markers, Clinical Correlates
    Circulating HER2 Extracellular Domain and Resistance to Chemotherapy in Advanced Breast Cancer
    Ramon Colomer, Sagrario Montero, Ana Lluch, Belén Ojeda, Agustí Barnadas, Antonio Casado, Bartomeu Massutí, Hernán Cortés-Funes and Belén Lloveras
    Clin Cancer Res June 1 2000 6 (6) 2356-2362;

  • Molecular Oncology, Markers, Clinical Correlates
    The Presence of Soluble c-erbB-2 in Saliva and Serum among Women with Breast Carcinoma: A Preliminary Study
    Charles Streckfus, Lenora Bigler, Tracy Dellinger, Xaoli Dai, Albert Kingman and J. Tate Thigpen
    Clin Cancer Res June 1 2000 6 (6) 2363-2370;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of BAX in Plasma Cell Dyscrasias
    Stephen Renner, Jeffrey Weisz, Stanislaw Krajewski, Maryla Krajewska, John C. Reed and Alan Lichtenstein
    Clin Cancer Res June 1 2000 6 (6) 2371-2380;

  • Molecular Oncology, Markers, Clinical Correlates
    Noninvasive Diagnosis of Bladder Carcinoma by Enzyme-linked Immunosorbent Assay Detection of CD44 Isoforms in Exfoliated Urothelia
    Anthony C. Woodman, Steve Goodison, Marcus Drake, Jeremy Noble and David Tarin
    Clin Cancer Res June 1 2000 6 (6) 2381-2392;

  • Molecular Oncology, Markers, Clinical Correlates
    Detection by Denaturant Gradient Gel Electrophoresis of Tumor-specific Mutations in Biopsies and Relative Bronchoalveolar Lavage Fluid from Resectable Non-Small Cell Lung Cancer
    Gianluigi Ferretti, Giuseppe Curigliano, Ugo Pastorino, Achille Cittadini, Giovanna Flamini, Maria Grazia Calabrò, Tommaso De Pas, Laura Orlando, Mario Mandalà, Marco Colleoni, Lorenzo Spaggiari, Pier Luigi Granone, Gabriella Pagliari, Filippo de Braud, Nicola Fazio and Aron Goldhirsch
    Clin Cancer Res June 1 2000 6 (6) 2393-2400;

  • Molecular Oncology, Markers, Clinical Correlates
    Increased Expression of an ATP-binding Cassette Superfamily Transporter, Multidrug Resistance Protein 2, in Human Colorectal Carcinomas
    Eiji Hinoshita, Takeshi Uchiumi, Ken-ichi Taguchi, Naoko Kinukawa, Masazumi Tsuneyoshi, Yoshihiko Maehara, Keizo Sugimachi and Michihiko Kuwano
    Clin Cancer Res June 1 2000 6 (6) 2401-2407;

  • Molecular Oncology, Markers, Clinical Correlates
    Inducible Nitric Oxide Synthase Expression, Apoptosis, and Angiogenesis in in Situ and Invasive Breast Carcinomas
    Merja Vakkala, Katriina Kahlos, Essi Lakari, Paavo Pääkkö, Vuokko Kinnula and Ylermi Soini
    Clin Cancer Res June 1 2000 6 (6) 2408-2416;

  • Molecular Oncology, Markers, Clinical Correlates
    Immunohistochemical Analyses of Focal Adhesion Kinase Expression in Benign and Malignant Human Breast and Colon Tissues: Correlation with Preinvasive and Invasive Phenotypes
    William G. Cance, Janet E. Harris, Mary V. Iacocca, Elizabeth Roche, XiHui Yang, Jinli Chang, Stephen Simkins and LiHui Xu
    Clin Cancer Res June 1 2000 6 (6) 2417-2423;

  • Molecular Oncology, Markers, Clinical Correlates
    Cyclooxygenase-2 Expression Is Up-Regulated in Transitional Cell Carcinoma and Its Preneoplastic Lesions in the Human Urinary Bladder
    Tsutomu Shirahama
    Clin Cancer Res June 1 2000 6 (6) 2424-2430;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma
    Toshiro Niki, Sanae Iba, Masahide Tokunou, Tesshi Yamada, Yoshihiro Matsuno and Setsuo Hirohashi
    Clin Cancer Res June 1 2000 6 (6) 2431-2439;

  • Molecular Oncology, Markers, Clinical Correlates
    Association between Polymorphism in p21Waf1/Cip1 Cyclin-dependent Kinase Inhibitor Gene and Human Oral Cancer
    Ranju Ralhan, Sandhya Agarwal, Meera Mathur, Bohdan Wasylyk and Anurag Srivastava
    Clin Cancer Res June 1 2000 6 (6) 2440-2447;

  • Molecular Oncology, Markers, Clinical Correlates
    Production and Pro-Apoptotic Activity of Soluble CD95 Ligand in Pancreatic Carcinoma
    Graziella Bellone, Carlo Smirne, Anna Carbone, Katia Mareschi, Luca Dughera, Enzo C. Farina, Oscar Alabiso, Guido Valente, Giorgio Emanuelli and Ulrich Rodeck
    Clin Cancer Res June 1 2000 6 (6) 2448-2455;

Experimental Therapeutics, Preclinical Pharmacology

  • Experimental Therapeutics, Preclinical Pharmacology
    Calpain Inhibitor II Induces Caspase-dependent Apoptosis in Human Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cells as Well as Some Solid Tumor Cells
    De-Min Zhu and Fatih M. Uckun
    Clin Cancer Res June 1 2000 6 (6) 2456-2463;

  • Experimental Therapeutics, Preclinical Pharmacology
    Antimetastatic Intraoperative Chemotherapy of Human Colon Tumors in the Livers of Nude Mice
    Babak Rashidi, Zili An, Fang-Xian Sun, A. R. Moossa and Robert M. Hoffman
    Clin Cancer Res June 1 2000 6 (6) 2464-2468;

  • Experimental Therapeutics, Preclinical Pharmacology
    Successful Treatment of Intracranial Gliomas in Rat by Oligodeoxynucleotides Containing CpG Motifs
    Antoine F. Carpentier, Jun Xie, Karima Mokhtari and Jean-Yves Delattre
    Clin Cancer Res June 1 2000 6 (6) 2469-2473;

  • Experimental Therapeutics, Preclinical Pharmacology
    Cytotoxic Chemotherapy Regimens That Increase Dose per Cycle (Dose Intensity) by Extending Daily Dosing from 5 Consecutive Days to 28 Consecutive Days and Beyond
    Kristan A. Keyes, Beatriz Albella, Patricia M. LoRusso, Juan A. Bueren and Ralph E. Parchment
    Clin Cancer Res June 1 2000 6 (6) 2474-2481;

  • Experimental Therapeutics, Preclinical Pharmacology
    Constitutive and Lysophosphatidic Acid (LPA)-induced LPA Production: Role of Phospholipase D and Phospholipase A2
    Astrid M. Eder, Takayo Sasagawa, Muling Mao, Junken Aoki and Gordon B. Mills
    Clin Cancer Res June 1 2000 6 (6) 2482-2491;

  • Experimental Therapeutics, Preclinical Pharmacology
    Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide
    Richard J. Klasa, Marcel B. Bally, Rebecca Ng, James H. Goldie, Randy D. Gascoyne and Frances M. P. Wong
    Clin Cancer Res June 1 2000 6 (6) 2492-2500;

  • Experimental Therapeutics, Preclinical Pharmacology
    The Relationship between Intracellular and Extracellular pH in Spontaneous Canine Tumors
    Deborah M. Prescott, H. Cecil Charles, Jean M. Poulson, Rodney L. Page, Donald E. Thrall, Zeljko Vujaskovic and Mark W. Dewhirst
    Clin Cancer Res June 1 2000 6 (6) 2501-2505;

  • Experimental Therapeutics, Preclinical Pharmacology
    Oral Antisense that Targets Protein Kinase A Cooperates with Taxol and Inhibits Tumor Growth, Angiogenesis, and Growth Factor Production
    Giampaolo Tortora, Roberto Bianco, Vincenzo Damiano, Gabriella Fontanini, Sabino De Placido, A. Raffaele Bianco and Fortunato Ciardiello
    Clin Cancer Res June 1 2000 6 (6) 2506-2512;

  • Experimental Therapeutics, Preclinical Pharmacology
    Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor
    Cordula Petersen, Sven Petersen, Luka Milas, Frederick F. Lang and Philip J. Tofilon
    Clin Cancer Res June 1 2000 6 (6) 2513-2520;

  • Experimental Therapeutics, Preclinical Pharmacology
    Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-1
    Carolien P. Schröder, Bart-Jan Kroesen, Lou F. M. H. de Leij and Elisabeth G. E. de Vries
    Clin Cancer Res June 1 2000 6 (6) 2521-2527;

  • Experimental Therapeutics, Preclinical Pharmacology
    Pegylated Liposomes Have Potential as Vehicles for Intratumoral and Subcutaneous Drug Delivery
    Kevin J. Harrington, Gail Rowlinson-Busza, Konstantinos N. Syrigos, Paul S. Uster, Richard G. Vile and J. Simon W. Stewart
    Clin Cancer Res June 1 2000 6 (6) 2528-2537;

  • Experimental Therapeutics, Preclinical Pharmacology
    Comparison of Thymidylate Synthase (TS) Protein Up-Regulation after Exposure to TS Inhibitors in Normal and Tumor Cell Lines and Tissues
    Sarah J. Welsh, Jenny Titley, Lisa Brunton, Melanie Valenti, Paul Monaghan, Ann L. Jackman and G. Wynne Aherne
    Clin Cancer Res June 1 2000 6 (6) 2538-2546;

  • Experimental Therapeutics, Preclinical Pharmacology
    A Novel Bispecific Antisense Oligonucleotide Inhibiting Both bcl-2 and bcl-xL Expression Efficiently Induces Apoptosis in Tumor Cells
    Uwe Zangemeister-Wittke, Siân H. Leech, Robert A. Olie, A. Paula Simões-Wüst, Oliver Gautschi, Gerd H. Luedke, François Natt, Robert Häner, Pierre Martin, Jonathan Hall, Carlo M. Nalin and Rolf A. Stahel
    Clin Cancer Res June 1 2000 6 (6) 2547-2555;

Cancer Biology, Immunology, Cytokines

  • Cancer Biology, Immunology, Cytokines
    An Orthotopic Mouse Model of Remetastasis of Human Colon Cancer Liver Metastasis
    Babak Rashidi, Reza Gamagami, Aaron Sasson, Fang Xian Sun, Jack Geller, A. R. Moossa and Robert M. Hoffman
    Clin Cancer Res June 1 2000 6 (6) 2556-2561;

  • Cancer Biology, Immunology, Cytokines
    The Relevance of Cell Proliferation, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor Production to Angiogenesis and Tumorigenicity in Human Glioma Cell Lines
    Li Dao Ke, Yue-Xi Shi, Seock-Ah Im, Xiashan Chen and W. K. Alfred Yung
    Clin Cancer Res June 1 2000 6 (6) 2562-2572;

  • Cancer Biology, Immunology, Cytokines
    Nuclear Factor-κB Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice
    Suyun Huang, Ariel DeGuzman, Corazon D. Bucana and Isaiah J. Fidler
    Clin Cancer Res June 1 2000 6 (6) 2573-2581;

Back to top
PreviousNext
June 2000
Volume 6, Issue 6
  • Table of Contents

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Advances in Brief
  • Clinical Trials
  • Molecular Oncology, Markers, Clinical Correlates
  • Experimental Therapeutics, Preclinical Pharmacology
  • Cancer Biology, Immunology, Cytokines
Advertisement
  • Most Cited
  • Most Read
Loading
  • Targeted TNF Potentiates the Efficacy of a Peptide Vaccine
  • WNT/β-catenin–Associated Immune Exclusion across Cancers
  • Alisertib for Neuroendocrine Prostate Cancer
  • Genotyping of HCC in the Clinic
  • Single-Cell RNA Sequencing of Pancreatic Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement